COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study. Issue 10 (22nd October 2022) - Niemann, Carsten U.; Awan, Farrukh T.; Fogliatto, Laura; Nikitin, Eugene; Samoilova, Olga; Habib, Adel; Foroutanpour, Kayhan; Kuptsova-Clarkson, Nataliya; Opat, Stephen